Thoracic Surgery Department

The Thoracic Surgery Department of the Second Hospital of Tianjin Medical University has 30 beds and currently has 23 medical staff, including 2 chief physicians, 3 deputy chief physicians, 1 master's tutor, 2 doctors with doctorate degrees, and 8 doctors with master's degrees. While performing routine thoracic surgery and chest trauma first aid, the department also features radioactive seed implantation for tumor treatment and minimally invasive surgery for thoracic tumors. In 2002, the department was the first in China to carry out radioactive seed implantation for the treatment of lung cancer (particle knife), and won the second prize of the Tianjin Science and Technology Progress Award. This technology has long been at the leading level at home and abroad. The department performs surgeries covering various chest diseases, and is at the leading level in Tianjin in terms of surgical volume, wide range of diseases, and technological innovation. Featured Technology Thoracoscopy is a representative surgery of minimally invasive thoracic surgery. The surgical incision is small and the appearance is beautiful. The patient can get out of bed the next day after the operation and can be discharged from the hospital in a short time. Our department has introduced an advanced 3D thoracoscopy system. 3D thoracoscopy restores the surgeon's natural three-dimensional vision and depth perception, reduces the difficulty of anatomy and the possibility of postoperative complications for patients, and improves the accuracy and overall surgical efficiency of surgical dissection, cutting, grasping, anastomosis, suturing, and hemostasis.3D thoracoscopy can not only shorten the operation time, but also detect the hidden small blood vessels in the lung tissue as early as possible, thereby truly achieving "zero bleeding" in the operation. At present, our department has performed hundreds of single-port thoracoscopic bullectomy, single-port thoracoscopic radical lung cancer resection, and total laparoscopic esophageal cancer radical resection. Especially single-port thoracoscopic surgery has only one 2-3 cm incision on the skin. It has small trauma, beautiful incision, early ambulation, and quick postoperative recovery, which achieves rapid recovery. In 2002, the Department of Thoracic Surgery was the first in China to develop standardized technology for percutaneous radioactive seed implantation under CT guidance in the treatment of lung cancer, making breakthrough progress. The original "joint technique" of CT combined with particle implantation under fiberoptic bronchoscopy can effectively remove obstructions in the large airways and kill tumors that invade the large airways, heart and large blood vessels and other important organs. So far, more than 3,000 cases of advanced lung cancer from all over the country have been treated. The effective rate is 94.5%, and the 1-year survival rate is 89%. The curative effect is very significant, and it won the second prize of Tianjin Science and Technology Achievement and Science and Technology Progress Award.While treating lung cancer, radioactive seed implantation has also been carried out to treat dozens of malignant solid tumors such as lymph node metastasis and bone metastasis, as well as particle-coated stents to treat esophageal cancer. Surgical resection of lung cancer and esophageal cancer has also included placement of seeds in the tumor bed to prevent local recurrence of tumors. The radioactive seed implantation treatment for lung cancer training course held every year is a national-level continuing education project and has trained hundreds of professional doctors in the country. With the development of intelligent life and medical care, the application of medical robots has become the frontier field and the commanding heights at the department level for domestic and foreign medical institutions to compete for the development of medical technology. Da Vinci surgical robot is recognized as the world's leading surgical robot in the industry. There are currently more than 5,300 units in the world and nearly 5 million operations have been performed. The fourth-generation da Vinci surgical robot is the latest generation of surgical robot in the world. Compared with previous laparoscopic surgeries, its main advantages include: (1) It has high synchronization and super stability, and can actively filter the physiological jitter of the human hand, significantly improving the safety of surgical operations. (2) The 3D high-definition naked-eye imaging system can magnify local tissues up to 15 times, greatly avoiding intraoperative damage to important nerves and blood vessels.(3) The special chair reduces the labor intensity of the surgeon, and the operation can be completed efficiently without standing for a long time, thus improving the efficiency of the operation. (4) The imaging is delicate, the three-dimensional effect is strong, the surgical field is clear and stable, and the field of view can be moved accurately at any time according to the surgeon's needs. (5) The robotic arm has high flexibility, and the instrument can accurately imitate the hand movements of the surgeon, and is even more flexible and reliable than the human hand under computer control. (6) Reduce surgical risks caused by operator fatigue and reduce perioperative infection risks. (7) The surgical field is wider than in previous surgeries, and the operation is intuitive and easy to carry out. The Second Hospital of Tianjin Medical University introduced the fourth-generation da Vinci surgical robot in 2019. It is the first hospital in the Beijing-Tianjin-Hebei and North China regions to introduce the fourth-generation da Vinci surgical robot. It has completed more than 300 surgeries in various disciplines. Thoracic surgery is one of the departments where da Vinci robotic surgery is most widely used. Under the guidance of the leaders of the hospital, our department will soon carry out relevant personnel training and surgical applications, which will greatly assist the development of our department. It will have great application in the surgical treatment of benign and malignant lung tumors, mediastinal tumors, esophageal tumors and other diseases, and will also lead the development of thoracic surgery in a more sophisticated direction.